In addition, the comparison of MMR deficiency cases showed that the PLS group had increased peritumoral immune marker expression (such as CD8+, PD-L1+, and PD-1+) compared to the MLH1 methylation cases. Here, CD8A is linked to mismatch repair cancer syndrome 1.